GL1X · GenesisL1 explorer

MolNFT v1 · #59133 · protein

Structure of the C. botulinum neurotoxin serotype a with an inhibitory peptide bound

3BOO · Neurotoxin a: “Structure of the C. botulinum neurotoxin serotype a with an inhibitory peptide bound”. X-ray diffraction, 2 ligands (ACE, ZN), 5 pockets (best druggability 0.54). MolNFT v1 #59133 on GenesisL1: 3D structure, binding…

PDB
3BOO
Type
protein
Length
426 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Neurotoxin a; N-ac-cratkml inhibitory peptide
EC
3.4.24.69
UniProt
A2I2U2
Ligands
ACE, ZN
Pockets
5 · best druggability 0.54

Structure

x-ray diffraction · 2 distinct chains · 33% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANeurotoxin a (EC 3.4.24.69)protein41932% helix, 19% strandA2I2U2
BN-ac-cratkml inhibitory peptideprotein757% helix, 0% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains A, B
  • ZN · Zinc ion · metal · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12420.540.7735empty
2760.440.8116empty
3650.330.7616empty
4630.310.7412empty
5560.260.7315empty

Interfaces

1 interface between chains.

  • A–B · 593 Ų buried · 12 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent, 1 modified (covalent ligand, oxidation).

Compared structures

  • 3BOO · Structure of the C. botulinum neurotoxin serotype A with an inhibitory peptide bound · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.